77284-32-3,
Fmoc-Nle-OH,
Fmoc-L-norleucine,
N-Fmoc-L-norleucine,
(S)-2-(Fmoc-amino)caproic acid,
MFCD00037537,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hexanoic acid,
N-(9-Fluorenylmethoxycarbonyl)-L-norleucine,
(S)-2-(9H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-HEXANOIC ACID,
FMOC-L-Norleucine, 98%,
(2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)hexanoic acid,
Fmoc-norleucine,
FmocNleOH,
Fmoc-Nle,
Fmoc-Ahx-OH,
Fmoc-Nle-OH.,
PubChem14958,
AC1Q2UOD,
AMOT0143,
SCHEMBL1000115,
Fmoc-(S)-2-aminohexanoic acid,
CTK3J7353,
DTXSID40426568,
VCFCFPNRQDANPN-IBGZPJMESA-N,
KS-000001GX,
ZINC2384875,
ANW-36992,
BBL102853,
CF-833,
STL556661,
AM82590,
CS-W009404,
RTR-024703,
AJ-35137,
AS-18993,
AB1002087,
TR-024703,
A7650,
FT-0629929,
ST24047280,
X4008,
N-(9H-Fluorene-9-ylmethoxycarbonyl)norleucine,
M-1128,
284F323,
J-300350,
N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-norleucine,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-norleucine,
Q-101634,
Fmoc-Nle-OH, >=98.0% (sum of enantiomers, HPLC),
Z2472511389,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)hexanoic acid,
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid,
(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}hexanoic acid,
(S)-2-(Fmoc-amino)caproic acid; (S)-2-(Fmoc-amino)hexanoic acid; N-(9-Fluorenylmethoxycarbonyl)-Lnorleucine,,
C21H23NO4,
2',7'-Dichlorofluorescein diacetate,
Fmoc-L-norleucine, 98% - 1G 1g,
ACN-033886,
CID7009636,
2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic Acid,
(S)-N-Fmoc-norleucine; Fmoc-norleucine; N-(9-Fluorenylmethoxycarbonyl)-L-norleucine,